Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases?

被引:138
作者
Baum, M
Demicheli, R
Hrushesky, W
Retsky, M
机构
[1] Portland Hosp, Emeritus Surg UCL, London W1W 5QN, England
[2] Milan Natl Canc Inst, Dept Med Oncol, I-20133 Milan, Italy
[3] Univ S Carolina, Sch Med, Columbia, SC 29208 USA
[4] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA
[5] Childrens Hosp, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Vasc Biol, Boston, MA 02115 USA
关键词
surgery; breast cancer; metastases; natural history;
D O I
10.1016/j.ejca.2004.09.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This historical perspective on breast cancer tells us how and why certain therapeutic eras have reached ascendancy and then declined. Therapeutic revolutions occur after a crisis develops when there is a general recognition that clinical interventions are not producing positive results predicted by the prevailing paradigm. The attitude of pre-modern surgeons was influenced by the very real possibility of doing more harm than good by operating upon women with breast cancer. Up until Halsted, the general consensus was clearly that, unless forced by the circumstances, surgical resection should be avoided for disease much more advanced than very early stage tumours (the cacoethesis of Celsus). Twentieth century progress in antisepsis, anaesthesia, and surgery changed this point of view. The first three quarters of that century saw more and more aggressive operations performed while the last quarter century reversed this trend, with reduction of the size of breast cancer operations based largely on the teachings of Fisher. A new crisis is upon us now in that trials of early detection have resulted in unexpected disadvantages to certain subgroups and there is previously unreported structure in early hazard of relapse, clinical data that suggests the act of surgery might accelerate the appearance of distant metastases. The explanation we propose that agrees with these results, as well as physicians of antiquity, is that surgery can induce angiogenesis and proliferation of distant dormant micrometastases, especially in young patients with positive nodes. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 59 条
[41]  
Naumov GN, 2002, CANCER RES, V62, P2162
[42]   Long-term effects of mammography screening:: updated overview of the Swedish randomised trials [J].
Nyström, L ;
Andersson, I ;
Bjurstam, N ;
Frisell, J ;
Nordenskjöld, B ;
Rutqvist, LE .
LANCET, 2002, 359 (9310) :909-919
[43]   Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy [J].
Overgaard, M ;
Hansen, PS ;
Overgaard, J ;
Rose, C ;
Andersson, M ;
Bach, F ;
Kjaer, M ;
Gadeberg, CC ;
Mouridsen, HT ;
Jensen, MB ;
Zedeler, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :949-955
[44]  
Paget S., 1989, LANCET, V8, P98, DOI DOI 10.1016/S0140-6736(00)49915-0
[45]   Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer [J].
Ragaz, J ;
Jackson, SM ;
Le, N ;
Plenderleith, IH ;
Spinelli, JJ ;
Basco, VE ;
Wilson, KS ;
Knowling, MA ;
Coppin, CML ;
Paradis, M ;
Coldman, AJ ;
Olivotto, IA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :956-962
[46]   Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients [J].
Retsky, M ;
Bonadonna, G ;
Demicheli, R ;
Folkman, J ;
Hrushesky, W ;
Valagussa, P .
BREAST CANCER RESEARCH, 2004, 6 (04) :R372-R374
[47]   Breast cancer screening: controversies and future directions [J].
Retsky, M ;
Demicheli, R ;
Hrushesky, W .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2003, 15 (01) :1-8
[48]   Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy [J].
Retsky, M ;
Demicheli, R ;
Hrushesky, W .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (03) :217-224
[49]   Annual hazard rates of recurrence for breast cancer after primary therapy [J].
Saphner, T ;
Tormey, DC ;
Gray, R .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2738-2746
[50]   A new biological framework for cancer research [J].
Schipper, H ;
Turley, EA ;
Baum, M .
LANCET, 1996, 348 (9035) :1149-1151